Roman Scharf
Partner @ 3VC
Vienna, Austria
Roman Scharf is a Series B investor at 3VC in Vienna focused on Software and Artificial Intelligence. General Partner at 3VC.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 38%
Last updated:
For AI agents: llms.txt
Industries Roman Scharf invests in
Stages Roman Scharf invests in
Countries Roman Scharf invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Series A
- $13M–$20M
- Series B
- $20M–$26M
Investment Focus
Industry
- Software 2 (25%)
- Artificial Intelligence 2 (25%)
- Energy 1 (13%)
- FinTech 1 (13%)
- Medical 1 (13%)
Stage
- Series B 3 (38%)
- Series A 2 (25%)
- Pre-Seed 1 (13%)
- Series C 1 (13%)
Country
- United States 4 (50%)
- Austria 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Pactum is an AI platform that automates commercial negotiations for businesses, allowing sales teams to engage in personalized discussions with suppliers. The platform streamlines the negotiation process, enabling companies to optimize contract terms and improve procurement efficiency. By leveraging advanced algorithms, Pactum analyzes data tosupport informed decision-making during negotiations. This approach helps organizations manage multiple supplier relationships effectively while reducing the time and resources spent on negotiations. Pactum's technology empowers sales development representatives to focus on strategic initiatives rather than administrative tasks, enhancing overall productivity within sales teams. | $20M / Series B / Jul 11, 2024 | ||
| Pactum is an AI platform that automates commercial negotiations for businesses, allowing sales teams to engage in personalized discussions with suppliers. The platform streamlines the negotiation process, enabling companies to optimize contract terms and improve procurement efficiency. By leveraging advanced algorithms, Pactum analyzes data tosupport informed decision-making during negotiations. This approach helps organizations manage multiple supplier relationships effectively while reducing the time and resources spent on negotiations. Pactum's technology empowers sales development representatives to focus on strategic initiatives rather than administrative tasks, enhancing overall productivity within sales teams. | $20M / Series A / Dec 08, 2022 | ||
| Kaia Health is a digital therapeutics company that creates evidence-based treatments for a range of disorders including back pain and COPD. Working with experts in various medical fields, the company uses machine learning to deliver individualized app interventions that aim to empower and motivate patients to take control and self-manage theircondition with digital alternatives from their home using devices they already own (i.e. smartphones and tablets).The company has enrolled more than 400,000 users to date in its digital therapy program. It was founded in 2016 and is headquartered in Brooklyn, New York. | $75M / Series C / Apr 28, 2021 | ||
| neoom is a software company that offers services clean and integrated decentralized energy solutions. It focuses on electrical and digital systems that create sustainable value. The company offers solutions in energy management, photovoltaics, power storage, charging stations, and a range of storage solutions. | $13.3M / Series A / Mar 01, 2021 | ||
| Zelf is a neobank targeting Gen Z to bring financial services to where they live – in messengers. This is the lightest bank with the easiest onboarding process taking up to 60 sec to issue a card, receive and send money without leaving the messenger. We are uniquely offering AI-powered voice control over the most of financial operations, whichmakes us first voice-enabled banking for Gen Z who prefers voice interactions with their devices. | $2M / Pre-Seed / Feb 25, 2021 | ||
| Kaia Health is a digital therapeutics company that creates evidence-based treatments for a range of disorders including back pain and COPD. Working with experts in various medical fields, the company uses machine learning to deliver individualized app interventions that aim to empower and motivate patients to take control and self-manage theircondition with digital alternatives from their home using devices they already own (i.e. smartphones and tablets).The company has enrolled more than 400,000 users to date in its digital therapy program. It was founded in 2016 and is headquartered in Brooklyn, New York. | $26M / Series B / Jun 18, 2020 | ||
| Picsart is the world’s largest digital creation platform. Its AI-powered tools allow creators of all levels to design, edit, draw and share photo and video content. Picsart has amassed one of the largest open-source content collections in the world, including photos, stickers, backgrounds, templates, and more. Used by consumers, marketers, contentcreators and businesses, Picsart is used for both personal and professional design. Available on mobile and web, Picsart offers its world class image editing and processing tools to businesses through APIs and an SDK. Headquartered in Miami, with offices around the world, Picsart is backed by SoftBank, Sequoia Capital, DCM Ventures, Insight Partners, and others. Download the app or visit picsart.com for more information. | $20M / Series B / Jul 01, 2019 | ||
| Picsart is the world’s largest digital creation platform. Its AI-powered tools allow creators of all levels to design, edit, draw and share photo and video content. Picsart has amassed one of the largest open-source content collections in the world, including photos, stickers, backgrounds, templates, and more. Used by consumers, marketers, contentcreators and businesses, Picsart is used for both personal and professional design. Available on mobile and web, Picsart offers its world class image editing and processing tools to businesses through APIs and an SDK. Headquartered in Miami, with offices around the world, Picsart is backed by SoftBank, Sequoia Capital, DCM Ventures, Insight Partners, and others. Download the app or visit picsart.com for more information. | $20M / Series B / Apr 20, 2016 |
Co-Investors
About 3VC
3VC is a venture capital fund that invests up to 10 million EUR tickets in carefully selected European tech startups with outrageous ambition and signs of product-market fit, focusing on companies from the DACH, CEE or Southern Europe region. 3VC’s backs category-defining companies like Assaia, Kaia Health, Lokalise, Picsart, Storyblok, and Tatum.
3VC Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Eva Arh
Partner
|
|||
Gerald Pollak
Investor
|
|||
|
Roman Scharf
Partner
|
|||
Federico Rota Candiani
Principal
|
|||
Kirsten Pöltl
Executive Assistant
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Roman Scharf invest in?
Roman Scharf invests primarily in Software, Artificial Intelligence and Energy startups, most often at Series B and Series A stage. Most of the 8 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Roman Scharf invest in?
Roman Scharf typically joins rounds of $13M–$20M at Series A and $20M–$26M at Series B. These are whole funding-round sizes, not Roman Scharf's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Roman Scharf took part in.
How do I contact Roman Scharf?
Public channels for Roman Scharf include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Roman Scharf last invest?
The most recent investment recorded for Roman Scharf closed in Jul 2024. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
